Arcus Biosciences (RCUS) Enterprise Value (2017 - 2026)
Arcus Biosciences (RCUS) posted quarterly Enterprise Value of -$822.0 million for Q1 2026, up 17.55% year-over-year from -$699.3 million in Q1 2025, and up 16.21% quarter-over-quarter from -$981.0 million in Q4 2025.
Arcus Biosciences (RCUS) Enterprise Value (2017 - 2026) Analysis & Trends
Arcus Biosciences' Enterprise Value history runs 10 years deep, the most recent figure standing at -$822.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 17.55% year-over-year to -$822.0 million; the TTM figure through Mar 2026 stood at -$822.0 million (up 17.55% YoY), while the FY2025 annual figure was -$981.0 million, changed 0.31% from the prior year.
- Enterprise Value for Q1 2026 stood at -$822.0 million, up from -$981.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$759.0 million in Q4 2023, with the low at -$1.2 billion in Q1 2022.
- The 5-year median for Enterprise Value is -$978.0 million (2024), against an average of -$968.2 million.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 102.2% in 2022, then advanced 24.78% in 2023.
- Arcus Biosciences' Enterprise Value stood at -$1.0 billion in 2022, then increased by 24.78% to -$759.0 million in 2023, then dropped by 28.85% to -$978.0 million in 2024, then slipped by 0.31% to -$981.0 million in 2025, then rose by 16.21% to -$822.0 million in 2026.
- Business Quant data shows RCUS's Enterprise Value at -$822.0 million in Q1 2026, -$981.0 million in Q4 2025, and -$831.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | -702.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -702.00 Mn |
| Mar 31, 2026 | -822.00 Mn |
| Dec 31, 2025 | -981.00 Mn |
| Sep 30, 2025 | -831.00 Mn |
| Jun 30, 2025 | -911.00 Mn |
| Mar 31, 2025 | -997.00 Mn |
| Dec 31, 2024 | -978.00 Mn |
| Sep 30, 2024 | -1.09 Bn |
| Jun 30, 2024 | -969.00 Mn |
| Mar 31, 2024 | -995.00 Mn |
| Dec 31, 2023 | -759.00 Mn |
| Sep 30, 2023 | -799.00 Mn |
| Jun 30, 2023 | -930.00 Mn |
| Mar 31, 2023 | -954.00 Mn |
| Dec 31, 2022 | -1.01 Bn |
| Sep 30, 2022 | -1.05 Bn |
| Jun 30, 2022 | -1.17 Bn |
| Mar 31, 2022 | -1.21 Bn |
| Dec 31, 2021 | -499.00 Mn |
| Sep 30, 2021 | -524.64 Mn |